Zhang X - Search Results

1

Efficacy Differences of First-line EGFR-TKIs Alone vs in Combination with Chemotherapy in Advanced Lung Adenocarcinoma Patients with Sensitive EGFR Mutation and Concomitant Non-EGFR Genetic Alterations.

Zhang G, Cheng R, Niu Y, Wang H, Yan X, Zhang M, Zhang X, Yang J, Wei C, Ma Z. Zhang G, et al. Among authors: zhang m, zhang x. Zhongguo Fei Ai Za Zhi. 2022 Sep 20;25(9):651-657. doi: 10.3779/j.issn.1009-3419.2022.102.34. Zhongguo Fei Ai Za Zhi. 2022. PMID: 36172729 Free PMC article.

2

Inhibition of NF-κB improves sensitivity to irradiation and EGFR-TKIs and decreases irradiation-induced lung toxicity.

Wang R, Peng S, Zhang X, Wu Z, Duan H, Yuan Y, Wang W. Wang R, et al. Among authors: zhang x. Int J Cancer. 2019 Jan 1;144(1):200-209. doi: 10.1002/ijc.31907. Epub 2018 Oct 31. Int J Cancer. 2019. PMID: 30289964

3

Apatinib as maintenance therapy in extensive-stage small-cell lung cancer: results from a single-center retrospective study.

Yan X, Wang Q, Wang H, Li P, Zhang G, Zhang M, Zheng X, Yang J, Zhang X, Ma Z. Yan X, et al. Among authors: zhang m, zhang g, zhang x. J Cancer Res Clin Oncol. 2019 Jan;145(1):235-240. doi: 10.1007/s00432-018-2764-8. Epub 2018 Oct 6. J Cancer Res Clin Oncol. 2019. PMID: 30293117 Free PMC article.

4

Efficacy of first-line treatment with epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) alone or in combination with chemotherapy for advanced non-small cell lung cancer (NSCLC) with low-abundance mutation.

Yan X, Wang H, Li P, Zhang G, Zhang M, Yang J, Zhang X, Zheng X, Ma Z. Yan X, et al. Among authors: zhang m, zhang g, zhang x. Lung Cancer. 2019 Feb;128:6-12. doi: 10.1016/j.lungcan.2018.12.007. Epub 2018 Dec 6. Lung Cancer. 2019. PMID: 30642455

5

Mutation tracking of a patient with EGFR-mutant lung cancer harboring de novo MET amplification: Successful treatment with gefitinib and crizotinib.

Zheng X, Zhang G, Li P, Zhang M, Yan X, Zhang X, Yang J, Li H, Liu X, Ma Z, Wang H. Zheng X, et al. Among authors: zhang m, zhang g, zhang x. Lung Cancer. 2019 Mar;129:72-74. doi: 10.1016/j.lungcan.2019.01.009. Epub 2019 Jan 23. Lung Cancer. 2019. PMID: 30797494

6

Efficacy and long-term survival of advanced lung adenocarcinoma patients with uncommon EGFR mutations treated with 1st generation EGFR-TKIs compared with chemotherapy as first-line therapy.

Li H, Wang C, Wang Z, Hu Y, Zhang G, Zhang M, Zheng X, Zhang X, Yang J, Ma Z, Wang H. Li H, et al. Among authors: zhang m, zhang g, zhang x. Lung Cancer. 2019 Apr;130:42-49. doi: 10.1016/j.lungcan.2019.02.001. Epub 2019 Feb 2. Lung Cancer. 2019. PMID: 30885350

7

Driver genes as predictive indicators of brain metastasis in patients with advanced NSCLC: EGFR, ALK, and RET gene mutations.

Wang H, Wang Z, Zhang G, Zhang M, Zhang X, Li H, Zheng X, Ma Z. Wang H, et al. Among authors: zhang m, zhang g, zhang x. Cancer Med. 2020 Jan;9(2):487-495. doi: 10.1002/cam4.2706. Epub 2019 Nov 25. Cancer Med. 2020. PMID: 31769228 Free PMC article.

8

Comparable outcomes of nivolumab in patients with advanced NSCLC presenting with or without brain metastases: a retrospective cohort study.

Zhang G, Cheng R, Wang H, Zhang Y, Yan X, Li P, Zhang M, Zhang X, Yang J, Niu Y, Ma Z. Zhang G, et al. Among authors: zhang m, zhang x, zhang y. Cancer Immunol Immunother. 2020 Mar;69(3):399-405. doi: 10.1007/s00262-019-02462-1. Epub 2020 Jan 6. Cancer Immunol Immunother. 2020. PMID: 31907567 Free PMC article.

9

Associations between peripheral blood lymphocyte subsets and clinical outcomes in patients with lung cancer treated with immune checkpoint inhibitor.

Li P, Qin P, Fu X, Zhang G, Yan X, Zhang M, Zhang X, Yang J, Wang H, Ma Z. Li P, et al. Among authors: zhang m, zhang g, zhang x. Ann Palliat Med. 2021 Mar;10(3):3039-3049. doi: 10.21037/apm-21-163. Ann Palliat Med. 2021. PMID: 33849094 Free article.

10

Sintilimab with two cycles of chemotherapy for the treatment of advanced squamous non-small cell lung cancer: a phase 2 clinical trial.

Zhang M, Zhang G, Niu Y, Zhang G, Ji Y, Yan X, Zhang X, Wang Q, Jing X, Wang J, Ma Z, Wang H. Zhang M, et al. Among authors: zhang g, zhang x. Nat Commun. 2024 Feb 19;15(1):1512. doi: 10.1038/s41467-024-45769-z. Nat Commun. 2024. PMID: 38374204 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

182,560 results

Search Page

Filters